Freedom of Information request on VAERS for reporting adverse reactions (FOI 21-724)
Updated 27 April 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-12-july-2021/freedom-of-information-request-on-vaers-for-reporting-adverse-reactions-foi-21-724
16th July 2021
FOI 21-724
Dear ,
Regarding your final question in the email dated 21st June 2021, please note that VAERS is the USA national system for reporting adverse reactions therefore the MHRA does not directly report UK deaths to this system.
The MHRA runs the Yellow Card Scheme which is the UK system for collecting and monitoring information on safety concerns such as suspected side effects or adverse incidents involving medicines and medical devices. The scheme relies on voluntary reporting of suspected side effects or medical device incidents to be reported by health professionals and the public, including patients, carers and parents. Data received via the Yellow Card Scheme for COVID-19 vaccines is published weekly and can be accessed via the link provided in our email below.
Kind regards,
Yellow Card Service Team (FF) Vigilance and Risk Management of Medicines Division